Literature DB >> 20617302

Metformin in type 1 diabetes reduces insulin requirements without significantly improving glycaemic control.

H Schatz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20617302     DOI： 10.1007/s00125-010-1844-3

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  4 in total

1.  Correlation of glucose regulation and hemoglobin AIc in diabetes mellitus.

Authors:  R J Koenig; C M Peterson; R L Jones; C Saudek; M Lehrman; A Cerami
Journal:  N Engl J Med       Date:  1976-08-19       Impact factor: 91.245

2.  Studies of an unusual hemoglobin in patients with diabetes mellitus.

Authors:  S Rahbar; O Blumenfeld; H M Ranney
Journal:  Biochem Biophys Res Commun       Date:  1969-08-22       Impact factor: 3.575

3.  Studies on juvenile--type diabetes in children. Assessment of control under treatment with constant and variable doses of insulin with or without addition of biguanides.

Authors:  H Schatz; G Winkler; E M Jonatha; E F Pfeiffer
Journal:  Diabete Metab       Date:  1975-12

Review 4.  The use of metformin in type 1 diabetes: a systematic review of efficacy.

Authors:  S Vella; L Buetow; P Royle; S Livingstone; H M Colhoun; J R Petrie
Journal:  Diabetologia       Date:  2010-01-08       Impact factor: 10.122
  4 in total
  2 in total

1.  Metformin in type 1 diabetes reduces insulin requirements without significantly improving glycaemic control. Reply to Schatz H [letter].

Authors:  S Vella; L Buetow; P Royle; S Livingstone; J R Petrie
Journal:  Diabetologia       Date:  2010-10-29       Impact factor: 10.122

2.  Case Reports That Illustrate the Efficacy of SGLT2 Inhibitors in the Type 1 Diabetic Patient.

Authors:  David S H Bell
Journal:  Case Rep Endocrinol       Date:  2015-02-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.